How Has the Tissue Heart Valves Market Size Evolved in Recent Years?
The tissue heart valves market has seen considerable growth due to a variety of factors.
• The marketplace for tissue heart valves has been experiencing consistent growth over the past few years. Its size is projected to climb from $1.48 billion in 2024 to $1.53 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 3.1%.
Factors contributing to the growth during the historic period include an uptick in lifestyle diseases, increased spending in healthcare, a rise in the aging population, and a surge in cardiac & pathological conditions, along with an elevated occurrence of heart diseases.
What Is The Forecast For The Tissue Heart Valves Market Size?
The tissue heart valves market is expected to maintain its strong growth trajectory in upcoming years.
• The market for tissue heart valves is predicted to sustain a steady rise in the forthcoming years. It is projected to escalate to $1.70 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 2.7%.
The expansion during the forecast period can be associated with the rising incidences of cardiovascular diseases, an uptrend in sutureless procedures, an enlarging senior population, an increased demand for cardiovascular therapies, and escalated investments in healthcare. The forecast period is set to witness significant trends like technological breakthroughs, innovative culture systems, advancements in the field of imaging technologies, evolving surgical methodologies, and growth in emerging markets.
What Are The Essential Drivers Behind The Growth Of The Tissue Heart Valves Market?
The tissue heart valves market is projected to grow, fuelled by the rising incidence of cardiovascular diseases. These diseases include a range of disorders that affect the heart and blood vessels, such as heart attacks, strokes, and hypertension. Various factors contribute to the increased prevalence of these diseases, including unhealthy lifestyles, aging, higher risk factors, poor dietary habits, lack of physical activity, smoking, stress, and urbanization, which all contribute to an elevated global rate of heart-related conditions. Tissue heart valves play an integral role in combating these diseases. They offer a biocompatible, durable, and less thrombogenic solution for patients requiring valve replacement and help to enhance long-term heart function and decrease the possibility of complications. As per a report from the Heart Failure Society of America (HFSA), a professional organization based in the US, in September 2024, approximately 6.7 million Americans over the age of 20 are currently dealing with heart failure (HF). Projections suggest that this count will surge to 8.7 million by 2030, 10.3 million by 2040, and 11.4 million by 2050 respectively. The escalating occurrence of cardiovascular diseases, therefore, stimulates the expansion of the tissue heart valve market.
How Is The Global Tissue Heart Valves Market Divided Into Key Segments?
The tissue heart valves market covered in this report is segmented –
1) By Type: Stented Tissue Heart Valves, Stentless Tissue Heart Valves
2) By Valve Type: Aortic, Mitral, Tricuspid, Pulmonary
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Stented Tissue Heart Valves: Bovine Pericardial Valves, Porcine Valves
2) By Stentless Tissue Heart Valves: Bovine Pericardial Stentless Valves, Homograft Valves
Pre-Book The Tissue Heart Valves Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Tissue Heart Valves Market?
Leading businesses in the tissue heart valves market are concentrating their efforts on creating innovative products such as surgical aortic tissue valves. These products are designed to simplify the implantation process and improve patient management over their lifetime. Surgical aortic tissue valve is a type of prosthetic heart valve that is created from biological tissue, often used as a replacement for a malfunctioning aortic valve during heart surgery. For example, in June 2024, the Ireland-based tech firm Medtronic plc. introduced the Avalus Ultra valve. This next-generation surgical aortic tissue valve aims to simplify the implantation process and ensure effective long-term patient care. With over a decade of clinical experience with the Avalus valve underpinning its design, the Avalus Ultra valve boasts a streamlined profile, a polyetheretherketone (PEEK) base frame to maintain its circular shape, and an industry-topping Effective Orifice Area (EOA) to enhance blood flow. The valve is also equipped with a radiopaque coil to ensure clear visibility during future valve-in-valve procedures. This enhances the longevity and durability for patients suffering from aortic stenosis.
Who Are the Key Players In The Tissue Heart Valves Market?
Major companies operating in the tissue heart valves market are:
• Abbott Laboratories
• Medtronic PLC
• Boston Scientific Corporation
• Edwards Lifesciences Corporation
• LivaNova PLC
• Meril Life Sciences Pvt. Ltd.
• MicroPort Scientific Corporation
• LifeNet Health Inc.
• TTK Healthcare Ltd.
• Braile Biomédica
• On-X Life Technologies Inc.
• Anteris Technologies Ltd.
• Labcor Laboratórios Ltd.
• CARDION s.r.o.
• CryoLife Inc.
• Colibri Heart Valve LLC
• Foldax Inc.
• Balance Medical Technologies Co. Ltd.
• MiCardia Corporation
• Neovasc Inc.
What Are The Regional Insights Into The Tissue Heart Valves Market?
North America was the largest region in the tissue heart valves market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tissue heart valves market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
